1995
Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.
Megibow A, Zhou X, Rotterdam H, Francis I, Zerhouni E, Balfe D, Weinreb J, Aisen A, Kuhlman J, Heiken J. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group. Radiology 1995, 195: 327-32. PMID: 7724748, DOI: 10.1148/radiology.195.2.7724748.Peer-Reviewed Original ResearchConceptsComputed tomographyT1-weighted spin-echo sequencesMR imagingPredictive valueSpin-echo sequenceCross-sectional imaging modalitiesInitial imaging assessmentUnresectable pancreatic carcinomaEvaluation of resectabilityAccuracy of CTT2-weighted spin-echo sequencesNegative predictive valuePositive predictive valueMagnetic resonanceAdult patientsOncology GroupHepatic metastasesVascular invasionPathologic resultsPancreatic adenocarcinomaImaging assessmentPancreatic carcinomaCT scanImaging modalitiesAdenocarcinoma
1994
Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging.
Mitchell D, Saini S, Weinreb J, De Lange E, Runge V, Kuhlman J, Parisky Y, Johnson C, Brown J, Schnall M. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 1994, 193: 49-57. PMID: 8090921, DOI: 10.1148/radiology.193.1.8090921.Peer-Reviewed Original Research